We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.3B
AUM Growth
+$177M
Cap. Flow
+$235M
Cap. Flow %
18.05%
Top 10 Hldgs %
40.67%
Holding
213
New
103
Increased
34
Reduced
21
Closed
43

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$47.9M
2
ABBV icon
AbbVie
ABBV
+$27.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$18.7M
4
LPSN icon
LivePerson
LPSN
+$16.1M
5
AZN icon
AstraZeneca
AZN
+$13.6M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$40.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$26.4M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$12.8M
4
ZYME icon
Zymeworks
ZYME
+$11.6M
5
META icon
Meta Platforms (Facebook)
META
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 62.55%
2 Technology 7.69%
3 Industrials 4.91%
4 Financials 2.93%
5 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.02T
$80.2M 6.15%
429,200
+19,200
+5% +$3.76M
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$74.6M 5.72%
453,900
+115,700
+34% +$18.7M
ABBV icon
3
AbbVie
ABBV
$443B
$64.9M 4.98%
599,500
+259,500
+76% +$27.8M
MRK icon
4
Merck
MRK
$322B
$62.4M 4.78%
847,631
+83,840
+11% +$6.18M
SNY icon
5
Sanofi
SNY
$103B
$49.4M 3.79%
+997,900
New +$47.9M
AZN icon
6
AstraZeneca
AZN
$263B
$47.8M 3.66%
480,237
+135,000
+39% +$13.6M
IWM icon
7
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$46.4M 3.56%
+210,000
New +$45.9M
ENPH icon
8
CALL
Enphase Energy
ENPH
$4.96B
$37.3M 2.86%
+230,000
New +$41.3M
GNRC icon
9
Generac Holdings
GNRC
$11.6B
$34.6M 2.65%
105,663
– –
JNJ icon
10
CALL
Johnson & Johnson
JNJ
$618B
$32.9M 2.52%
+200,000
New +$32.4M
IGV icon
11
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
$24.2M 1.86%
+354,500
New +$25.1M
FVRR icon
12
CALL
Fiverr
FVRR
$321M
$21.7M 1.67%
+100,000
New +$24.5M
KURA icon
13
Kura Oncology
KURA
$800M
$20.3M 1.56%
717,751
+246,257
+52% +$7.79M
CCCC icon
14
C4 Therapeutics
CCCC
$385M
$18.4M 1.41%
497,136
+53,312
+12% +$2.12M
MSFT icon
15
Microsoft
MSFT
$3.45T
$15.9M 1.22%
67,536
+20,000
+42% +$4.64M
KRNT icon
16
Kornit Digital
KRNT
$705M
$14.7M 1.13%
148,381
+20,000
+16% +$1.98M
SNDX icon
17
Syndax Pharmaceuticals
SNDX
$1.69B
$14.3M 1.09%
638,093
-107,807
-14% -$2.44M
LPSN icon
18
LivePerson
LPSN
$21.8M
$13.7M 1.05%
+17,333
New +$16.1M
EPIX
19
DELISTED
ESSA Pharma
EPIX
$13.6M 1.05%
469,241
+79,041
+20% +$1.84M
AUDC icon
20
AudioCodes
AUDC
$244M
$12.8M 0.98%
475,624
+46,653
+11% +$1.39M
BMY icon
21
Bristol-Myers Squibb
BMY
$133B
$12.6M 0.97%
200,000
-425,000
-68% -$26.4M
ONCR
22
DELISTED
Oncorus, Inc.
ONCR
$12.6M 0.96%
903,111
– –
CERE
23
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$12.5M 0.96%
912,240
+100,575
+12% +$1.47M
ATER icon
24
CALL
Aterian
ATER
$4.45M
$10.5M 0.8%
+29,633
New +$11.4M
PANW icon
25
Palo Alto Networks
PANW
$270B
$10.4M 0.8%
193,800
-33,426
-15% -$1.99M
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2021 Portfolio in Review

As of Q1 2021, Sphera Funds Management held 213 positions worth $1.3B, up 16% from $1.13B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sphera Funds Management deployed $235M of net new capital in Q1 2021, opening 103 new positions and adding to 34 existing holdings. Its largest new stake was Sanofi: 997,900 shares worth $49.4M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 68% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $26.4M trimmed.

  • Sphera Funds Management's largest Q1 2021 buy was Sanofi: 997,900 shares worth $49.4M.
  • Sphera Funds Management added most to AbbVie in Q1 2021, an estimated $27.8M increase.
  • Sphera Funds Management's biggest Q1 2021 reduction was Bristol-Myers Squibb, cutting an estimated $26.4M.
  • Sphera Funds Management fully exited Novartis in Q1 2021, selling an estimated $40.5M.
  • Sphera Funds Management's ten largest holdings make up 41% of its $1.3B portfolio in Q1 2021.
  • Sphera Funds Management opened 103 new positions and closed 43 in Q1 2021.
  • Sphera Funds Management's portfolio value rose 16% quarter-over-quarter to $1.3B.

Based on Sphera Funds Management's 13F filing for Q1 2021, filed 17 May 2021.